Description
Trading suspended for T-bill ISIN IN001225C076 (SCRIP CODE 800448) maturing on December 16, 2025, effective from December 12, 2025.
Summary
BSE has announced the suspension of trading in a Treasury Bill (T-bill) with ISIN IN001225C076 (SCRIP CODE 800448) effective from December 12, 2025. The suspension is due to the maturity of the security on its redemption date of December 16, 2025. Trading members are advised not to deal in this T-bill from the effective date.
Key Points
- T-bill with SCRIP CODE 800448 and ISIN IN001225C076 (GS16DEC2025C) to be suspended from trading
- Maturity/Redemption Date: December 16, 2025
- Trading suspension effective from: December 12, 2025
- Notice issued under reference DR-776/2025-2026
- Applies to Debt segment
Regulatory Changes
No regulatory framework changes. This is a standard operational notice for securities approaching maturity.
Compliance Requirements
- Trading members must cease all dealing in the mentioned T-bill from December 12, 2025
- Trading members should update their systems to reflect the trading suspension
- Members must ensure no new positions are created in this security
Important Dates
- Notice Date: December 11, 2025
- Trading Suspension Effective Date: December 12, 2025
- T-bill Maturity/Redemption Date: December 16, 2025
Impact Assessment
Market Impact: Low - This is a routine administrative action for a single government security reaching maturity. The suspension affects only one T-bill and is a standard market practice.
Operational Impact: Minimal - Trading members need to update their systems to block trading in this specific security. The short notice period (1 day) is standard for maturity-related suspensions as the security is close to its redemption date.
Investor Impact: Low - Holders of this T-bill will receive redemption proceeds on December 16, 2025. No action required from investors holding the security until maturity.
Impact Justification
Routine trading suspension for a single maturing T-bill with short notice period; standard market procedure with minimal market-wide impact.